Wockhardt Limited (NSE:WOCKPHARMA)
1,356.70
-8.60 (-0.63%)
Nov 6, 2025, 2:30 PM IST
Wockhardt Market Cap
Wockhardt has a market cap or net worth of 221.85 billion as of November 6, 2025. Its market cap has increased by 31.68% in one year.
Market Cap
221.85B
Enterprise Value
240.20B
Revenue
30.09B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,356.70
Market Cap Chart
Since February 21, 2001, Wockhardt's market cap has increased from 17.40B to 221.85B, an increase of 1,174.73%. That is a compound annual growth rate of 10.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 221.85B | -3.63% |
| Dec 31, 2024 | 230.20B | 276.45% |
| Dec 29, 2023 | 61.15B | 90.30% |
| Dec 30, 2022 | 32.13B | -29.77% |
| Dec 31, 2021 | 45.75B | -24.44% |
| Dec 31, 2020 | 60.55B | 133.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.05T |
| Divi's Laboratories | 1.81T |
| Cipla | 1.21T |
| Apollo Hospitals Enterprise | 1.12T |
| Mankind Pharma | 978.03B |
| Zydus Lifesciences | 977.76B |
| Fortis Healthcare | 769.38B |
| Alkem Laboratories | 677.22B |